<sup>18</sup>F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
Hong Song, Andrei Iagaru, Steven P. Rowe
Abstract
<sup>18</sup>F-DCFPyL was recently approved by the FDA for evaluation prior to definitive therapy and for biochemical recurrence. Here we focus on the key data that justify the clinical use of <sup>18</sup>F-DCFPyL, as well as those aspects of protocol implementation and image interpretation that are important to the nuclear medicine physicians and radiologists who will interpret <sup>18</sup>F-DCFPyL PET/CT and PET/MR scans.
Topics & Concepts
Food and drug administrationMedical physicsNuclear medicineProtocol (science)Interpretation (philosophy)MedicineComputer sciencePathologyPharmacologyAlternative medicineProgramming languageRadiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and ApplicationsLymphoma Diagnosis and Treatment